C. Montpellier et al., IN-VIVO AND IN-VITRO EPSTEIN-BARR-VIRUS A SSOCIATED LYMPHOPROLIFERATIVE DISORDERS, MS. Medecine sciences, 14(6-7), 1998, pp. 690-697
Since its discovery in cultured lymphoblasts from African Burkitt's ly
mphoma in 1964, the Epstein-Barr virus or EBV has been associated to v
arious types of malignancies such as infectious mononucleosis, nasopha
ryngeal carcinoma and Hodgkin's disease. It has been shown that the EB
V is associated to B lymphocytes in lymphoproliferative disorders. It
also appears to be linked, however, to a variety of non-Hodgkin's T ly
mphomas and T leukemias. Lymphoblastoid cell lines (or LCLs) are readi
ly established by EBV infection in vitro but we have shown that it tva
s also possible to transform peripheral T-cells in vitro after EBV inf
ection. In these naive T-cell lines, the two EBV genes EBNA1 and LMP1
are both expressed which is a characteristic of most of the EBV-associ
ated T malignancies. The study of these transformed T-cells could be v
ery useful for understanding the involvement of EBV in T lymphoprolife
rative disorders.